|
1
|
Shahbaaz M, Bisetty K, Ahmad F and Hassan
MI: Towards new drug targets? function prediction of putative
proteins of Neisseria meningitidis MC58 and their virulence
characterization. OMICS. 19:416–434. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Silva GP, Cruz SC, Cruz AC and Milagres
LG: Short-term and long-term antibody response by mice after
immunization against Neisseria meningitidis B or diphtheria toxoid.
Braz J Med Biol Res. 46:148–153. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ying S, He J, Yu M, Zhang Y, Deng S, Zhang
L, Xie M and Hu S: Recombinant Neisseria surface protein A is a
potential vaccine candidate against Neisseria meningitides
serogroup B. Mol Med Rep. 10:1619–1625. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pelton SI: The global evolution of
meningococcal epidemiology following the introduction of
meningococcal vaccines. J Adolesc Health. 59 Suppl 2:S3–S11. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Braunstein M, Rajkumar P, Claus CL,
Vaccarelli G, Moore AJ, Wang D and Anderson MK: HEBAlt enhances the
T-cell potential of fetal myeloid-biased precursors. Int Immunol.
22:963–972. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brehony C, Rodrigues CM, Borrow R, Smith
A, Cunney R, Moxon ER and Maiden MCJ: Distribution of
bexsero® antigen sequence types (BASTs) in invasive
meningococcal disease isolates: Implications for immunisation.
Vaccine. 34:4690–4697. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sung JW, Hsieh SY, Lin CL, Leng CH, Liu
SJ, Chou AH, Lai LW, Lin LH, Kwok Y, Yang CY and Chong P:
Biochemical characterizations of Escherichia coli-expressed
protective antigen Ag473 of Neisseria meningitides group B.
Vaccine. 28:8175–8182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khatami A and Pollard AJ: The epidemiology
of meningococcal disease and the impact of vaccines. Expert Rev
Vaccines. 9:285–298. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Martin D, Brodeur BR, Hamel J, Couture F,
de Alwis U, Lian Z, Martin S, Andrews D and Ellis RW: Candidate
Neisseria meningitidis NspA vaccine. J Biotechnol. 83:27–31. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang X, Yang X, Yang C, Wu Z, Xu H and
Shen Y: Crystal structure of outer membrane protein NMB0315 from
Neisseria meningitidis. PLoS One. 6:e268452011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee J, Kang HE and Woo HJ: Protective
immunity conferred by the C-terminal fragment of recombinant
Pasteurella multocida toxin. Clin Vaccine Immunol. 19:1526–1531.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fang Y, Lin H, Ma Z and Fan H:
Construction and immunogenicity of recombinant swinepox virus
expressing outer membrane protein L of salmonella. J Microbiol
Biotechnol. 26:1173–1181. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Borrow R, Carlone GM, Rosenstein N, Blake
M, Feavers I, Martin D, Zollinger W, Robbins J, Aaberge I, Granoff
DM, et al: Neisseria meningitidis group B correlates of protection
and assay standardization-International Meeting Report Emory
University, Atlanta, Georgia, United States, 16–17 March 2005.
Vaccine. 24:5093–5107. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Johansson L, Rytkonen A, Bergman P,
Albiger B, Källström H, Hökfelt T, Agerberth B, Cattaneo R and
Jonsson AB: CD46 in meningococcal disease. Science. 301:373–375.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sjölinder H and Jonsson AB: Olfactory
nerve-a novel invasion route of Neisseria meningitidis to reach the
meninges. PLoS One. 5:e140342010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chaudhari A, Pathakota GB and Annam PK:
Design and construction of shrimp antiviral DNA vaccines expressing
long and short hairpins for protection by RNA interference. Methods
Mol Biol. 1404:225–240. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Abdulhaqq SA and Weiner DB: DNA vaccines:
Developing new strategies to enhance immune responses. Immunol Res.
42:219–232. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu QQ, Zhang QH and Ma L: Construction of
recombinant eukaryotic expression plasmid pcDNA3.1(+)-mtDNA of
human colorectal carcinoma cells. Di Yi Jun Yi Da Xue Xue Bao.
25:1016–1019. 2005.(In Chinese). PubMed/NCBI
|
|
19
|
Cheng WK, Plumb AW, Lai JC, Abraham N and
Dutz JP: Topical CpG oligodeoxynucleotide adjuvant enhances the
adaptive immune response against influenza A infections. Front
Immunol. 7:2842016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hemmi H, Takeuchi O, Kawai T, Kaisho T,
Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K and
Akira S: A Toll-like receptor recognizes bacterial DNA. Nature.
408:740–745. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu HM, Wang J, Zhang B, Fang L, Xu K and
Liu RY: CpG-ODN promotes phagocytosis and autophagy through JNK/P38
signal pathway in Staphylococcus aureus-stimulated macrophage. Life
Sci. 161:51–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Buchanan RM, Briles DE, Arulanandam BP,
Westerink MA, Raeder RH and Metzger DW: IL-12-mediated increases in
protection elicited by pneumococcal and meningococcal conjugate
vaccines. Vaccine. 19:2020–2028. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gong W, Qi Y, Xiong X, Jiao J, Duan C and
Wen B: Rickettsia rickettsii outer membrane protein YbgF induces
protective immunity in C3H/HeN mice. Hum Vaccin Immunother.
11:642–649. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Trotter CL, Yaro S, Njanpop-Lafourcade BM,
Drabo A, Kroman SS, Idohou RS, Sanou O, Bowen L, Findlow H,
Diagbouga S, et al: Seroprevalence of bactericidal, specific IgG
antibodies and incidence of meningitis due to group A Neisseria
meningitidis by age in Burkina Faso 2008. PLoS One. 8:e554862013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bash MC, Lynn F, Mocca B, Borrow R,
Findlow H, Hassan-King M, Preziosi MP, Idoko O, Sow S, Kulkarni P
and Laforce FM: Development and use of a serum bactericidal assay
using pooled human complement to assess responses to a
meningococcal group A conjugate vaccine in African toddlers. Clin
Vaccine Immunol. 21:755–761. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Findlow J, Holland A, Andrews N, Weynants
V, Sotolongo F, Balmer P, Poolman J and Borrow R: Comparison of
phenotypically indistinguishable but geographically distinct
Neisseria meningitidis group B isolates in a serum bactericidal
antibody assay. Clin Vaccine Immunol. 14:1451–1477. 2007.
View Article : Google Scholar : PubMed/NCBI
|
